Centrum Leczenia Uzależnień Zeus Detox & Rehab
| Turcja | Austria | Hiszpania | |
| Leczenie szpitalne (za 1 dzień) | od $350 | od $1,200 | od $800 |
| Pobyt osoby towarzyszącej (za 1 dzień) | od $50 | od $150 | od $100 |
Państwo nie płacą za usługi Bookimed. Ceny na leczenie szpitalne (za 1 dzień) na stronie odpowiadają cennikowi kliniki. Płatność dokonywana jest bezpośrednio w klinice po przyjeździe. Dostępna jest płatność w ratach.
Bookimed dba o Państwa bezpieczeństwo. Współpracujemy tylko z klinikami spełniającymi wysokie międzynarodowe standardy w przeprowadzaniu leczenia szpitalnego (za 1 dzień). Posiadają one wymagane licencje do obsługi pacjentów międzynarodowych na całym świecie.
Bookimed oferuje bezpłatną pomoc i wsparcie. Osobisty koordynator medyczny pozostaje w kontakcie przed, w trakcie i po podróży. Nie będą Państwo sami w innym kraju podczas procedury Leczenie szpitalne (za 1 dzień).
Day 1
Day 2
Day 3
Day 4-7
Week 1-2
Week 3-4
Week 5-6
Please note that the process may vary slightly as each case is individual.
Dr. Łukasz Maciejewski is a specialist in anesthesiology and intensive care medicine and in emergency medicine. He graduated from the Pomeranian Medical University in Szczecin. He completed additional training in Poland and Germany.
He gained clinical experience at the 109th Military Hospital in Szczecin. He also worked in German centers: Vivantes Klinikum im Friedrichshain (Berlin), Kreiskrankenhaus Wolgast gGmbH, and Asklepios Klinikum Uckermark (Schwedt/Oder).
He holds DEGUM certifications in ultrasonography and regional anesthesia (German Society for Ultrasound in Medicine). He supervises apheresis procedures at Nowoczesna Afereza. He speaks Polish, German, and English.
Dr. med. Adam Macech is a general surgeon and emergency medicine physician with over 40 years of practice in Poland and abroad. He leads the emergency care unit at Warsaw Southern Hospital. He also oversees blood purification (apheresis) at Nowoczesna Afereza. He served as a medical expert with the Polish Military Contingent in Iraq. He worked on the front line in dedicated COVID-19 hospitals. He has also provided medical care aboard a vessel in the North Pacific.
He graduated from the Medical University of Lublin. He completed an NHS clinical placement in Dorchester, UK. He holds postgraduate diplomas in organ transplant coordination and coloproctology from the Jagiellonian University in Kraków.
His career includes roles at the Military Institute of Medicine in Warsaw, the Railway Hospital in Pruszków, the Barska Trauma Center in Warsaw, the Department of Vascular Surgery and Transplantology at the Central Clinical Hospital in Warsaw, and the Specialist Hospital in Biała Podlaska. He lectures, writes, and speaks at national and international emergency medicine conferences.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.